Show simple item record

dc.contributor.authorWorld Health Organization, Regional Office for South-East Asia
dc.coverage.spatialNew Delhi: WHO Regional Office for South-East AsiaEN
dc.date.accessioned2014-07-26T02:50:04Z
dc.date.available2014-07-26T02:50:04Z
dc.date.issued2008-08-25
dc.identifier.govdocSEA/RC61/27
dc.identifier.urihttps://apps.who.int/iris/handle/10665/128711
dc.description.abstractThe meeting of the Advisory Committee to review technical matters to be discussed at the Sixty-first Session of the Regional Committee, held in the Regional Office for South- East Asia from 30 June to 3 July 2008,proposed the issue of counterfeit medicines as an agenda item for the Regional Committee. It was agreed that the subject merits attention but members expressed concern that various issues pertaining to counterfeit medicines such as definition, terminology and other aspects were not fully understood. For example, in recent documents the scope has been expanded from medicines to medical products. Also, the magnitude of the problem of counterfeit medicines in Member countries of the South-East Asia Region is not known and needs to be assessed after these issues are clarified. Therefore, it was recommended that the Regional Office organize a meeting to clarify the various issues related to counterfeit medicines/medical products. An Inter-country Consultation on Combating Counterfeit Medicines was held at the Regional Office in New Delhi, 7-8 August 2008. This paper summarizes the meeting’s discussion and recommendations.EN
dc.language.isoenEN
dc.publisherWHO Regional Office for South-East AsiaEN
dc.titleSEA/RC61/27 - Counterfeit medicinesEN
dc.typeGoverning body documentsEN


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record